Cabozantinib in the treatment of advanced renal cell carcinoma: design, development, and potential place in the therapy

Cabozantinib in the treatment of advanced renal cell carcinoma: design, development, and potential place in the therapy

Paolo Grassi, Elena Verzoni, Raffaele Ratta, Alessia Mennitto, Filippo de Braud, Giuseppe Procopio Department of Medical Oncology, Genitourinary Cancer Unit, Fondazione IRCCS Istituto nazionale Tumori, Milan, Italy Abstract: The treatment of metastatic renal cell carcinoma (mRCC) has markedly impr...

Full description

Bibliographic Details
Main Authors: Grassi P, Verzoni E, Ratta R, Mennitto A, de Braud F, Procopio G
Format: Article
Language:English
Published: Dove Medical Press 2016-07-01
Series:Drug Design, Development and Therapy
Subjects:
cabozantinib
XL-184
metastatic renal cell carcinoma
VEGF-inhibitor
C-Met
targeted therapy
Online Access:https://www.dovepress.com/cabozantinib-in-the-treatment-of-advanced-renal-cell-carcinoma-design--peer-reviewed-article-DDDT

Internet

https://www.dovepress.com/cabozantinib-in-the-treatment-of-advanced-renal-cell-carcinoma-design--peer-reviewed-article-DDDT

Similar Items